• PF-573228: A FAK Inhibitor Research Guide

  2026-08-25

  PF-573228 is an ATP-competitive FAK inhibitor with a reported biochemical IC50 of 4 nM. It is a research tool for testing FAK-dependent adhesion, migration, survival, angiogenesis, and mechanotransduction rather than a validated clinical treatment.

• Halazone: A Redox-Aware Guide to Dual Assays

  2026-08-24

  Halazone is an antimicrobial sulfonamide derivative whose activity depends on oxidant availability, assay matrix, and exposure time. This guide connects water-disinfection performance with voltage-clamp evidence while defining practical controls, stability limits, and interpretation safeguards.

• HotStart qPCR Master Mix for Cell Assays

  2026-08-24

  This scenario-driven guide shows how HotStart™ Universal 2X FAST Green qPCR Master Mix (Rox), SKU K1172, can strengthen gene expression readouts in cell viability, proliferation, and cytotoxicity workflows. It covers inhibitor tolerance, ROX compatibility, melt-curve verification, protocol setup, interpretation, and practical supplier selection.

• AEBSF.HCl in Protease and Necroptosis Assays

  2026-08-23

  AEBSF.HCl is an irreversible serine protease inhibitor with applications spanning amyloid precursor protein processing, cell lysis, and mechanistic necroptosis assays. This guide focuses on a critical experimental distinction: suppressing serine proteases is not equivalent to blocking lysosomal cathepsin B.

• Antibiotic-Resistant E. coli in Hanoi Rodents

  2026-08-22

  This study characterizes antimicrobial-resistant Escherichia coli carried by urban rodents in Hanoi, Vietnam, linking phenotypic resistance with multidrug resistance, ESBL production, colistin resistance, and a diarrheagenic E. coli-associated gene. Its findings support rodents as useful sentinels for environmental AMR surveillance while showing why isolate-level resistance data should not be interpreted as evidence of direct zoonotic transmission or clinical treatment failure.

• CLK2, BRCA1, and Platinum Resistance in Ovarian Cancer

  2026-08-21

  The reference study identifies Cdc2-like kinase 2 (CLK2) as a clinically relevant mediator of platinum resistance in ovarian cancer and connects its activity to BRCA1 Ser1423 phosphorylation and DNA damage repair. Its tissue, cell, and xenograft evidence supports CLK2 as a mechanistic target, while also defining important limits when translating CLK-family pharmacology into therapeutic studies.

• Levofloxacin Workflows for Resistance and Bone Assays

  2026-08-20

  Levofloxacin connects bacterial DNA replication studies with controlled investigations of osteoblast and cartilage biology. This practical guide translates resistance-surveillance findings into assay design, preparation, optimization, and troubleshooting decisions.

• ACE2 Peptidase Selectivity Shapes Angiotensin (1-7)

  2026-08-20

  Saulnier and colleagues used a fluorogenic substrate-competition assay to map how angiotensin peptide length and terminal residues influence ACE2 peptidase activity. Their results identify Ang II and Ang III as the strongest natural competitors among the tested peptides, while showing that removal of the C-terminal phenylalanine fundamentally changes substrate recognition.

• EPI-001: Androgen Receptor N-Terminal Workflows

  2026-08-19

  EPI-001 enables pathway-focused studies of full-length androgen receptor and AR splice variants that can escape ligand-binding-domain inhibitors. This practical guide translates its N-terminal mechanism into dose-response, prostate cancer, CRPC, and AR-positive TNBC workflows with troubleshooting checkpoints.

• Sodium Dicloxacillin Monohydrate: Assay Design

  2026-08-19

  Sodium dicloxacillin monohydrate requires more than a single concentration or readout to interpret reliably. This guide links solid-form handling, selective analytical chemistry, PBP biology, pH effects, and MSSA assay design into a practical measurement framework.

• Hydroxytyrosol in Nicotine-Linked Kidney Research

  2026-08-18

  Hydroxytyrosol offers a scientifically useful way to examine oxidative stress modulation in nicotine-associated kidney injury models. This article translates receptor, redox, and fibrosis findings into practical assay decisions while defining the limits of current evidence.

• MVC Entry Through RhoA/ROCK1 Tight-Junction Remodeling

  2026-08-18

  Ren et al. show that Minute Virus of Canines VP2 directly interacts with ROCK1 and activates the RhoA/ROCK1/MLC2 axis in canine cells. The resulting actomyosin contraction disrupts tight junction organization, exposes occludin, and promotes MVC infection, identifying host junctional remodeling as a potential antiviral intervention point.

• Vacuolin-1: Lysosomal Exocytosis Inhibitor Guide

  2026-08-17

  Vacuolin-1 is a cell-permeable lysosomal exocytosis inhibitor that blocks Ca2+-dependent lysosome–plasma membrane fusion. Its reported assay uses include β-hexosaminidase release, Lamp-1 surface exposure, plasma membrane repair research, and lysosome-mediated membrane trafficking studies.

• Olive Oil Polyphenols and Cardiovascular Protection

  2026-08-17

  A 2025 study compared standard- and high-phenolic extra virgin olive oil extracts with hydroxytyrosol and tyrosol in cellular models of oxidative stress, inflammation, and cholesterol efflux. Its main contribution is showing that phenolic concentration and compound identity both influence antioxidant, anti-inflammatory, and anti-atherogenic responses, with hydroxytyrosol producing particularly strong effects in cholesterol handling assays.

• PD98059 MEK Inhibitor: Workflows & Troubleshooting

  2026-08-16

  Use PD98059 to connect MEK–ERK1/2 pathway inhibition with cell-cycle, differentiation, and apoptosis readouts in leukemia research. This practical guide also shows how to adapt the compound for neuroprotection in ischemia model studies while separating validated evidence from assay-development recommendations.

8049 records 1/537 page Next 12345 下5页 Last page